Erratum to: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma (Nature Medicine, (2018), 24, 11, (1649-1654), 10.1038/s41591-018-0197-1)

11Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the version of this article originally published, there was an error in Fig. 2b. RECIST ORR and pCR were both listed as 25%. RECIST ORR was actually 73%, and pCR was 45%. Also, an author’s name was incorrect in the author list. Danny K. Wells should have been listed as Daniel K. Wells. The errors have been corrected in the print, HTML and PDF versions of this article.

Cite

CITATION STYLE

APA

Amaria, R. N., Reddy, S. M., Tawbi, H. A., Davies, M. A., Ross, M. I., Glitza, I. C., … Wargo, J. A. (2018, December 1). Erratum to: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma (Nature Medicine, (2018), 24, 11, (1649-1654), 10.1038/s41591-018-0197-1). Nature Medicine. Nature Publishing Group. https://doi.org/10.1038/s41591-018-0251-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free